Sangamo Therapeutics Inc (SGMO) — Free Cash Flow Generation Index
Sangamo Therapeutics Inc (SGMO) has a Free Cash Flow Generation Index of 0.99x as of September 2024. Free cash flow of $11.64 Million represents 1% of operating cash flow ($11.76 Million). Explore Sangamo Therapeutics Inc (SGMO) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sangamo Therapeutics Inc Free Cash Flow Generation Index (2017–2020)
Historical FCF Generation Index trend for Sangamo Therapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see Sangamo Therapeutics Inc (SGMO) cash flow conversion.
Annual Free Cash Flow Generation for Sangamo Therapeutics Inc (2017–2020)
Year-by-year Free Cash Flow Generation Index for Sangamo Therapeutics Inc. Check cash flow reinvestment rate of Sangamo Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.91x | $155.16 Million | $169.88 Million | $14.71 Million | ▲ +673.9% |
| 2018 | -0.16x | $-5.91 Million | $37.15 Million | $43.06 Million | ▼ -124.0% |
| 2017 | 0.66x | $7.43 Million | $11.18 Million | $3.75 Million | — |